Continuum Advisory’s ARK Genomic Revolution ETF ARKG Stock Holding History

Continuum Advisory’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$76.3K	Buy	+1,814	New	+$57.8K	0.01%	701
2025 Q2	–	Sell	-3,837	Closed	-$79.7K	–	487
2025 Q1	$79.7K	Hold	3,837	–	–	0.01%	562
2024 Q4	$90.3K	Hold	3,837	–	–	0.01%	540
2024 Q3	$92.6K	Hold	3,837	–	–	0.01%	537
2024 Q2	$90.1K	Hold	3,837	–	–	0.01%	506
2024 Q1	$96.3K	Buy	+3,837	New	+$115K	0.01%	494
2022 Q1	–	Sell	-3,581	Closed	-$219K	–	377
2021 Q4	$219K	Sell	3,581 -84	-2%	-$5.81K	0.05%	278
2021 Q3	$274K	Hold	3,665	–	–	0.07%	234
2021 Q2	$339K	Sell	3,665 -312	-8%	-$26.5K	0.11%	199
2021 Q1	$359K	Buy	+3,977	New	+$394K	0.15%	124

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Continuum Advisory's ARKG Position: Q2 2026 in Review

Continuum Advisory opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 1,814 shares worth $76.3K. The stake represents 0.01% of the portfolio and ranks #701 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in ARKG as recently as Q1 2025.

Continuum Advisory first reported a position in ARKG in Q1 2021 and has held it in 10 quarters since. The position peaked at $359K in Q1 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Continuum Advisory held 1,814 shares of ARK Genomic Revolution ETF worth $76.3K as of Q2 2026.
ARK Genomic Revolution ETF was a new Continuum Advisory position in Q2 2026.
ARK Genomic Revolution ETF made up 0.01% of Continuum Advisory's portfolio in Q2 2026, its #701 holding.
Continuum Advisory first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 10 quarters since.
Continuum Advisory's ARK Genomic Revolution ETF position peaked at $359K in Q1 2021.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.